52 results
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics, Inc.
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
be material to a reasonable shareholder’s understanding of the independence, or lack thereof, of such Nominee; and if such information is requested
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics, Inc.
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
be material to a reasonable shareholder’s understanding of the independence, or lack thereof, of such Nominee; and if such information is requested
8-K
EX-1.1
LCTX
Lineage Cell Therapeutics, Inc.
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
knowledge, the Accountant is not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act
8-K
EX-99.1
8nqiyy e8pp9
12 Mar 20
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:15pm
8-K
EX-3.2
ocnmizb7 xi
12 Aug 19
Amendments to Articles of Incorporation or Bylaws
9:00am